Orthopaedisches Spital Speising GmbH
- Address
- lock Available on a paid plan
Hip Arthroplasty – Fast‑Track Recovery
The Orthopaedisches Spital Speising GmbH conducts research in hip arthroplasty within a fast‑track protocol that emphasizes early mobilization and brief hospital stay, aiming to test whether a shortened course of direct oral anticoagulant therapy is as effective as the traditional longer regimen in preventing blood clots.
- Reduced duration of postoperative thromboprophylaxis
- Early patient discharge after surgery
- Comparison of safety outcomes with standard anticoagulation
This work supports the hospital’s commitment to enhancing recovery pathways for patients undergoing elective primary hip replacement in Vienna.
Patellofemoral Osteoarthritis – Tissue‑Engineered Cartilage
At the same site, investigators explore innovative solutions for patellofemoral osteoarthritis by implanting tissue‑engineered nasal cartilage (N‑TEC) and measuring improvement with the KOOS‑5 score, seeking a superior clinical outcome compared with current standard procedures.
- Regenerative approach to knee joint cartilage
- Long‑term functional assessment over two years
- Evaluation against established microfracture technique
The trial reflects the hospital’s focus on advancing musculoskeletal therapies and offering patients cutting‑edge treatment options.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 152 other sites in Austria
Therapeutic Area Benchmark — Austria
Select a therapeutic area to compare against other sites in Austria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Austria
Market Share
Country: Austria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Orthopaedisches Spital Speising GmbH
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Rivaroxaban for Thromboprophylaxis in Patients Undergoing Elective Unilateral Primary Hip Arthroplasty Following ERAS Protocol | Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR | Phase III | Recruiting | Nov 2024 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| N-Tec | 1 | Unknown | 2025-06-30 | 2025-06-30 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.